NCT05656768Enrolling by invitation
Sleep and Circadian Contributions to Nighttime Blood Pressure
Source: ClinicalTrials.gov · Last updated 29 Jan 2026
Brief summary (registry, in English)
Broadly, this study (SCN-BP) seeks to examine sleep and circadian factors that contribute to blood pressure levels at night.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 1427 (estimated)
- First submitted
- 18 Nov 2022
- Start date
- 1 Jun 2023
- Primary completion date
- 30 Dec 2028
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- High blood pressure
- NCT number
- NCT05656768
What you commit to
- Study type: Interventional
- Planned participants: 1427
- From 1 Jun 2023 to the primary completion date, 30 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Participant in the parent grant (IDH-MEGA)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.